Quantoom Biosciences is leading the revolution in mRNA-based vaccines and therapeutics by providing turnkey solutions for mRNA-LNP manufacturing. Its cutting-edge Ntensify™ technology enables the production and purification of mRNA through a fully integrated, scalable system that combines processes, equipment, reagent mixes, and disposables. This solution supports the entire spectrum of mRNA production, from R&D to commercial manufacturing. Quantoom Biosciences is also developing the Ncapsulate™ technology for mRNA-LNP formulation and purification, aiming to significantly increase the accessibility and affordability of mRNA-based drugs.